Literature DB >> 8252891

High prevalence of asymptomatic esophageal and gastric lesions in preterm infants in intensive care.

M Mäki1, T Ruuska, A L Kuusela, R Karikoski-Leo, R S Ikonen.   

Abstract

OBJECTIVE: To establish the prevalence of upper gastrointestinal mucosal lesions in full-term and preterm infants under stress.
DESIGN: A prospective, cohort study.
SETTING: Neonatal intensive care unit at a university teaching hospital. PATIENTS: Seventeen (14 preterm, 3 term; median gestational age 29.7 wks; median birth weight 1230 g) consecutive, unselected infants treated in intensive care.
INTERVENTIONS: Gastroscopy, using a prototype fiberoptic gastroscope designed for newborns, was performed for the first time at the age of 3 to 7 days. Biopsy specimens were taken when possible. Ranitidine treatment and follow-up endoscopies were performed in selected patients. Blood pressure, heart rate, oxygen saturation by pulse oximeter, and the general condition of the infants were monitored at 1-min intervals during the endoscopy. Central nervous system ultrasonography examination was repeatedly performed before and after the procedure.
MEASUREMENTS AND MAIN RESULTS: At the time of first endoscopy, 15 of 17 infants were asymptomatic for gastrointestinal tract problems, one had melena, and one hematemesis. Upper gastrointestinal endoscopy revealed pathology in 16 (94%) infants, macroscopic esophagitis in six infants, hemorrhagic gastritis in nine infants, and gastritis with ulcers in six infants. Microscopically, the lesions were also clear. A peculiar finding was acute gastritis with cystic gland deformation ("cystic gastritis") seen in five of the infants under stress; one of these infants also had intestinal metaplasia in the gastric mucosa. Seven infants were treated with ranitidine without side-effects. Follow-up endoscopies demonstrated normalization of the lesions in five of six infants studied. The procedure, including biopsies, seemed to be safe, even for very low-birth weight infants.
CONCLUSIONS: Gastric mucosal lesions are highly prevalent in preterm infants in intensive care before any symptoms occur. Further research on preterm infants under stress is needed in order to determine the risk factors and optimal treatment for the esophageal and gastric mucosal lesions described here.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8252891     DOI: 10.1097/00003246-199312000-00013

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  8 in total

1.  Long-term gastric pH monitoring for determining optimal dose of ranitidine for critically ill preterm and term neonates.

Authors:  A L Kuusela
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-03       Impact factor: 5.747

Review 2.  Gastric ontogeny: clinical implications.

Authors:  E J Kelly; S J Newell
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-09       Impact factor: 5.747

3.  Upper GI bleeding among neonates admitted to Mulago Hospital, Kampala, Uganda: a prospective cohort study.

Authors:  O M Ombeva; G Ndeezi; J Mugalu
Journal:  Afr Health Sci       Date:  2013-09       Impact factor: 0.927

4.  Pharmacological interventions for prevention and treatment of upper gastrointestinal bleeding in newborn infants.

Authors:  Daniel Stephen Green; Mohamed E Abdel-Latif; Lisa J Jones; Kei Lui; David A Osborn
Journal:  Cochrane Database Syst Rev       Date:  2019-07-02

5.  Massive upper gastrointestinal bleeding due to a gastric ulcer in a newborn.

Authors:  Hasan Akduman; Nurdan Dinlen Fettah; Ayşegül Tok; Rümeysa Çitli; Başak Kaya Gürsoy
Journal:  Proc (Bayl Univ Med Cent)       Date:  2022-04-05

Review 6.  Pharmacokinetics of intravenous omeprazole in critically ill paediatric patients.

Authors:  Maria Jose Solana; Jesús López-Herce
Journal:  Eur J Clin Pharmacol       Date:  2009-12-30       Impact factor: 2.953

7.  Effect of osteopathic manipulative treatment on gastrointestinal function and length of stay of preterm infants: an exploratory study.

Authors:  Gianfranco Pizzolorusso; Patrizia Turi; Gina Barlafante; Francesco Cerritelli; Cinzia Renzetti; Vincenzo Cozzolino; Marianna D'Orazio; Paola Fusilli; Fabrizio Carinci; Carmine D'Incecco
Journal:  Chiropr Man Therap       Date:  2011-06-28

8.  Acid reducing agents to neonates - lack of evidence and guidelines.

Authors:  Stina Paulsson; Staffan Eksborg; Åsa Andersson; Per Nydert; Lena Grahnquist
Journal:  J Drug Assess       Date:  2012-01-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.